Prevalence and Risk Factors Associated with Cytolytic Vaginosis in Women from the Coffee Region, Colombia


Authors

DOI:

https://doi.org/10.22517/25395203.25940

Keywords:

vaginal discharge, prevalence, risk factors, Microbiota

Abstract

Introduction: Cytolytic vaginosis is a controversial and underrecognized condition that is often overlooked in women presenting with vaginal discharge syndrome. Therefore, the aim of this study was to determine the prevalence of cytolytic vaginosis and to identify associated risk factors.

Materials and Methods: A cross-sectional study was conducted in 197 women with vaginal discharge, attended at three referral clinics in the Coffee Region (Colombia) between February and November 2024. Diagnosis was established according to Cibley’s criteria. Sociodemographic, reproductive, sexual, behavioral, personal history, and intimate hygiene variables were analyzed. Odds ratios (OR) and their corresponding 95% confidence intervals (95% CI) were calculated.

Results: The mean age of participants was 34.68 ± 5.29 years. The prevalence of cytolytic vaginosis was 23.85% (n=47/197). Among menopausal women, prevalence was 36.11% (n=13/36), compared to 21.11% (n=34/161) in non-menopausal women. Associations were found with the use of home remedies (OR = 7.51; 95% CI: 3.7–15.2), intimate hair removal (OR = 7.02; 95% CI: 3.6–13.8), and infidelity (OR = 6.79; 95% CI: 2.9–16.2). Condom use (OR = 0.28; 95% CI: 0.1–0.7) and the use of cotton underwear (OR = 0.35; 95% CI: 0.1–0.9; p<0.05) showed a protective association.

Conclusions: The prevalence of cytolytic vaginosis is high among women in the Coffee Region. Its symptoms should be actively assessed in patients presenting with vaginal discharge syndrome. Further research is required to confirm its presence in our setting and to ensure accurate diagnosis and effective treatment.

Downloads

Download data is not yet available.

Author Biography

Franklin José, Clínica La Sagrada Familia

Dr. Franklin J. Espitia De La Hoz

Ginecología y Obstetricia

Universidad Militar Nueva Granada

Uroginecología, Vulvovaginoplastía y Rejuvenecimiento vaginal con láser

FUCS / UNAL / INICAMP, Brasil

Máster en Sexología: Educación y asesoramiento sexual

Universidad de Alcalá de Henares

References

Espitia De La Hoz FJ. Vaginosis citolítica: actualización diagnóstica y terapéutica. Rev Chil Obstet GineCOl. 2023;88(6):375-81. http://dx.doi.org/10.24875/RECHOG.23000056.

Zidovsky J. The significance of parabasal (“postnatal”) cells in the vaginal smear in prolonged pregnancy. Acta Cytol. 1961:5:393–398.

Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol. 1991 Oct;165(4 Pt 2):1245-9. doi: 10.1016/s0002-9378(12)90736-x. PMID: 1951582.

Ricci P, Contreras L, Contreras L. VAGINOSIS CITOLÍTICA: UN DIAGNÓSTICO DIFERENCIAL POCO FRECUENTE DE VULVOVAGINITIS MICÓTICA A REPETICIÓN. REV CHIL OBSTET GINECOL 2010; 75(3):194-8.

Osset J, García E, Bartolomé RM, Andreu A. Papel de Lactobacillus como factor protector de la candidiasis vaginal [Role of Lactobacillus as protector against vaginal candidiasis]. Med Clin (Barc). 2001 Sep 22;117(8):285-8. Spanish. doi: 10.1016/s0025-7753(01)72089-1. PMID: 11571120.

Suresh A, Rajesh A, Bhat RM, Rai Y. Cytolytic vaginosis: A review. Indian J Sex Transm Dis AIDS. 2009 Jan;30(1):48-50. doi: 10.4103/0253-7184.55490. PMID: 21938117; PMCID: PMC3168042.

Cerikcioglu N, Beksac MS. Cytolytic vaginosis: misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol. 2004;12(1):13-6. doi: 10.1080/10647440410001672139. PMID: 15460190; PMCID: PMC1784587.

Hillier SL, Krohn MA, Klebanoff SJ, Eschenbach DA. The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol. 1992 Mar;79(3):369-73. doi: 10.1097/00006250-199203000-00008. PMID: 1738516.

Hu Z, Zhou W, Mu L, Kuang L, Su M, Jiang Y. Identification of cytolytic vaginosis versus vulvovaginal candidiasis. J Low Genit Tract Dis. 2015 Apr;19(2):152-5. doi: 10.1097/LGT.0000000000000076. PMID: 25279977.

Kraut R, Carvallo FD, Golonka R, Campbell SM, Rehmani A, Babenko O, Lee MC, Vieira-Baptista P. Scoping review of cytolytic vaginosis literature. PLoS One. 2023 Jan 26;18(1):e0280954. doi: 10.1371/journal.pone.0280954. PMID: 36701339; PMCID: PMC9879469.

Kaufman R, Friedrich E, Gardner H. Benign diseases of the vulva and vagina. 3rd ed. Chicago: Year Book Medical Publishers; 1989:437.

Varma K, Kansal M. Cytolytic vaginosis: A brief review. J Skin Sex Transm Dis. 2022; 1-5. doi: 10.25259/JSSTD_41_2021.

Secor RM. Cytolytic vaginosis: a common cause of cyclic vulvovaginitis. Nurse Pract Forum. 1992 Sep;3(3):145-8. PMID: 1472886.

Demirezen S. Cytolytic vaginosis: examination of 2947 vaginal smears. Cent Eur J Public Health. 2003 Mar;11(1):23-4. PMID: 12690799.

Komec S, Aydin MD. A Little-Known Vaginitis-Like Picture: Cytolytic Vaginosis. Clin Lab. 2025 Jan 1;71(1). doi: 10.7754/Clin.Lab.2024.240709. PMID: 39808145.

Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan;74(1):14-22. doi: 10.1016/0002-9343(83)91112-9. PMID: 6600371.

Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991 Feb;29(2):297-301. doi: 10.1128/jcm.29.2.297-301.1991. PMID: 1706728; PMCID: PMC269757.

Yang S, Zhang Y, Liu Y, Wang J, Chen S, Li S. Clinical Significance and Characteristic Clinical Differences of Cytolytic Vaginosis in Recurrent Vulvovaginitis. Gynecol Obstet Invest. 2017;82(2):137-143. doi: 10.1159/000446945. Epub 2016 Jun 15. PMID: 27300413.

Batashki I, Markova D, Milchev N. [Frequency of cytolytic vaginosis--examination of 1152 patients]. Akush Ginekol (Sofiia). 2009;48(5):15-6. Bulgarian. PMID: 20198791.

Crann SE, Cunningham S, Albert A, Money DM, O'Doherty KC. Vaginal health and hygiene practices and product use in Canada: a national cross-sectional survey. BMC Womens Health. 2018 Mar 23;18(1):52. doi: 10.1186/s12905-018-0543-y. PMID: 29566756; PMCID: PMC5865287.

Hull T, Hilber AM, Chersich MF, Bagnol B, Prohmmo A, Smit JA, Widyantoro N, Utomo ID, François I, Tumwesigye NM, Temmerman M; WHO GSVP Study Group. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Womens Health (Larchmt). 2011 Jul;20(7):1097-109. doi: 10.1089/jwh.2010.2281. Epub 2011 Jun 13. PMID: 21668355.

Saraf VS, Sheikh SA, Ahmad A, Gillevet PM, Bokhari H, Javed S. Vaginal microbiome: normalcy vs dysbiosis. Arch Microbiol. 2021 Sep;203(7):3793-3802. doi: 10.1007/s00203-021-02414-3. Epub 2021 Jun 13. PMID: 34120200.

Espitia De La Hoz FJ. Influencia de la depilación íntima en la aparición de infecciones vulvovaginales y urinarias. Rev Asoc Colomb Dermatol. 2021;29(3): 187-95. DOI: https://doi.org/10.29176/2590843X.1390

Bradshaw CS, Walker SM, Vodstrcil LA, Bilardi JE, Law M, Hocking JS, Fethers KA, Fehler G, Petersen S, Tabrizi SN, Chen MY, Garland SM, Fairley CK. The influence of behaviors and relationships on the vaginal microbiota of women and their female partners: the WOW Health Study. J Infect Dis. 2014 May 15;209(10):1562-72. doi: 10.1093/infdis/jit664. Epub 2013 Nov 27. PMID: 24285846.

Downloads

Published

2026-05-16

How to Cite

Franklin José. (2026). Prevalence and Risk Factors Associated with Cytolytic Vaginosis in Women from the Coffee Region, Colombia. Revista Médica De Risaralda, 32(1), 23–35. https://doi.org/10.22517/25395203.25940

Issue

Section

Original Article